Rxsight Inc (RXST) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Rxsight Inc   (NASDAQ: RXST)
 

Rxsight Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the first quarter 2026, Rxsight Inc 's inventory turnover ratio sequentially decreased to 0.96 in the first quarter 2026, unsurprisingly, as the Rxsight Inc markets continue to deteriorate, and RXST's faces growing challenges to bring down its inventories. Rxsight Inc 's average inventory processing period in the Mar 31 2026 quarter, has increased to 380 days, from 320 days, in the Dec 31 2025 quarter.

Within Healthcare sector 318 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2026, to 1273, from total ranking in the fourth quarter 2025 at 1292.

RXST Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Rxsight Inc Market Share?

What is Inventory Turnover Ratio?




RXST Inventory Turnover Ratio (Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
Y / Y Inventory Growth 47.91 % 43.39 % 33.58 % 28.89 % 26.06 %
Y / Y Cost of Sales Growth -22.22 % -33.33 % -40 % -20 % 12.5 %
Inventory Turnover Ratio (TTM) 0.96 1.14 1.41 1.69 1.89
RXST's Total Ranking # 1273 # 1292 # 1090 # 989 # 941
Average inventory processing period 379 321 260 216 193
Seq. Inventory Growth 10.49 % 9.01 % 15.52 % 6.31 % 7.11 %
Seq. Cost of Sales Growth -12.5 % 33.33 % -25 % -11.11 % -25 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 145
Healthcare Sector # 319
Overall Market # 1273

Inventory Turnover Ratio Statistics
High Average Low
2.42 1.89 0.96
(Mar 31 2022)   (Mar 31 2026)




Financial Statements
Rxsight Inc 's Inventories $ 35 Millions Visit RXST's Balance sheet
Rxsight Inc 's Cost of Revenues TTM $ 29 Millions Visit RXST's Income Statement
What are RXST's Sales? Visit RXST's Sales by Segment

Other Inventory Turnover Ratios
Rxsight Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
RXST's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for RXST's Competitors
Inventory Turnover Ratio for RXST's Suppliers
Inventory Turnover Ratio for RXST's Customers

You may also want to know
RXST's Sales Growth Rates RXST's Pe Price to earnings ratio RXST's Receivables Turnover Ratio RXST's Stock Quote
RXST's Net Income Growth Rates RXST's Ps Price to Sales ratio RXST's Sales per Employee RXST's Asset Turnover Ratio
RXST's Net Margin RXST's Pb Price to Book ratio RXST's Financial Strength Ratios RXST's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2026 Inventories at quarter ending Mar 31 2026
Vivos Inc  2.27 $ 0.136  Millions$ 0  Millions
Beta Bionics Inc   2.26 $ 47.000  Millions$ 21  Millions
Resmed Inc   2.26 $ 2,094.000  Millions$ 928  Millions
Apyx Medical Corp  2.26 $ 20.000  Millions$ 9  Millions
Tela Bio Inc   2.25 $ 26.000  Millions$ 12  Millions
Eton Pharmaceuticals Inc   2.21 $ 39.000  Millions$ 18  Millions
Johnson and Johnson  2.20 $ 31,005.000  Millions$ 14,083  Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  2.19 $ 11.133  Millions$ 5  Millions
Icu Medical Inc  2.18 $ 1,338.223  Millions$ 615  Millions
Zomedica Corp   2.18 $ 12.298  Millions$ 6  Millions
Medtronic Plc  2.17 $ 12,721.000  Millions$ 5,867  Millions
Bio techne Corp  2.17 $ 424.000  Millions$ 196  Millions
Repligen Corp  2.16 $ 359.567  Millions$ 166  Millions
Neuroone Medical Technologies Corp  2.15 $ 4.423  Millions$ 2  Millions
Embecta Corp   2.15 $ 398.000  Millions$ 185  Millions
Boston Scientific Corporation  2.15 $ 6,358.000  Millions$ 2,961  Millions
Ultragenyx Pharmaceutical Inc   2.15 $ 110.338  Millions$ 51  Millions
Yunhong Green Cti Ltd   2.14 $ 18.000  Millions$ 8  Millions
Inspiremd Inc   2.14 $ 7.000  Millions$ 3  Millions
Phibro Animal Health Corporation  2.13 $ 1,010.688  Millions$ 475  Millions
Accuray Incorporated  2.11 $ 313.685  Millions$ 149  Millions
Amphastar Pharmaceuticals Inc   2.09 $ 379.402  Millions$ 181  Millions
Axsome Therapeutics Inc   2.06 $ 52.414  Millions$ 25  Millions
Clearpoint Neuro Inc   2.05 $ 15.298  Millions$ 7  Millions
Journey Medical Corp  2.05 $ 22.352  Millions$ 11  Millions
Fortress Biotech Inc   2.05 $ 22.352  Millions$ 11  Millions
Lifevantage Corp  2.04 $ 41.000  Millions$ 20  Millions
Bausch and Lomb Corp  2.04 $ 2,046.000  Millions$ 1,002  Millions
Organon and Co   2.03 $ 2,908.000  Millions$ 1,430  Millions
Innoviva Inc   2.03 $ 84.000  Millions$ 41  Millions

Date modified: 2026-08-30T15:02:40+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.